Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Andrei

Showing results (11-20 of 148) with videos related to

Pageof 15
Sort By:
International Journal of Antimicrobial Agents|August 1, 1994
Chemotherapy of varicella zoster virus infectionsR Snoeck, G Andrei, E De Clercq
Expert Opinion on Investigational Drugs|November 4, 2000
Novel agents for the therapy of varicella-zoster virus infectionsR Snoeck, G Andrei, E De Clercq
Current Opinion in Infectious Diseases|October 13, 2006
Specific therapies for human papilloma virus infectionsR Snoeck, G Andrei, E De Clercq
Antimicrobial Agents and Chemotherapy|April 4, 1998
The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivoJ Neyts, G Andrei, E De Clercq
Future Cardiology|July 15, 2025
Contemporary antiarrhythmic pharmacotherapy: revisiting the old, exploring the newStefan Totolici, Raluca Popescu, G-Andrei Dan
Medecine Et Maladies Infectieuses|January 29, 2005
[Using antiviral drugs for Orthopoxvirus infections]R Snoeck, E de Clercq, G Andrei
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 1996
Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitroR Snoeck, G Andrei, E De Clercq
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|July 5, 2001
Cidofovir in the treatment of HPV-associated lesionsR Snoeck, G Andrei, E De Clercq
Antimicrobial Agents and Chemotherapy|July 1, 1995
Susceptibilities of several drug-resistant herpes simplex virus type 1 strains to alternative antiviral compoundsG Andrei, R Snoeck, E De Clercq
Antiviral Research|June 1, 2004
In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?G Andrei, E De Clercq, R Snoeck
Pageof 15

Showing results (11-20 of 148) with videos related to

Sort By:
Pageof 15
International Journal of Antimicrobial Agents|August 1, 1994
Chemotherapy of varicella zoster virus infectionsR Snoeck, G Andrei, E De Clercq
Expert Opinion on Investigational Drugs|November 4, 2000
Novel agents for the therapy of varicella-zoster virus infectionsR Snoeck, G Andrei, E De Clercq
Current Opinion in Infectious Diseases|October 13, 2006
Specific therapies for human papilloma virus infectionsR Snoeck, G Andrei, E De Clercq
Antimicrobial Agents and Chemotherapy|April 4, 1998
The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivoJ Neyts, G Andrei, E De Clercq
Future Cardiology|July 15, 2025
Contemporary antiarrhythmic pharmacotherapy: revisiting the old, exploring the newStefan Totolici, Raluca Popescu, G-Andrei Dan
Medecine Et Maladies Infectieuses|January 29, 2005
[Using antiviral drugs for Orthopoxvirus infections]R Snoeck, E de Clercq, G Andrei
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 1996
Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitroR Snoeck, G Andrei, E De Clercq
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|July 5, 2001
Cidofovir in the treatment of HPV-associated lesionsR Snoeck, G Andrei, E De Clercq
Antimicrobial Agents and Chemotherapy|July 1, 1995
Susceptibilities of several drug-resistant herpes simplex virus type 1 strains to alternative antiviral compoundsG Andrei, R Snoeck, E De Clercq
Antiviral Research|June 1, 2004
In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?G Andrei, E De Clercq, R Snoeck
Pageof 15